Cardiovascular Diseases


BP and Heart Rate Patterns Prognostic

A longitudinal cohort study in Italy suggested that non-dipping and reverse dipping blood pressure (BP) patterns are associated with an increased prevalence of cardiac autonomic neuropathy and reduced survival. The study recruited 349 diabetic patients (52% women, age 57.1±11.9 y, BMI 29.4±5.9 kg/m2, HbA1c 8.6±2.1%, 284 with type 2 diabetes) […]


Cumulative LDL-C Linked to CVD

A pooled US cohorts study suggests that maintaining an optimal level of low-density lipoprotein cholesterol (LDL-C) throughout young adulthood and middle age can minimize the lifetime risk for atherosclerotic cardiovascular disease (CVD). The study included data of 18 288 participants (mean age 56.4, 56.4% women) collected from 1971 to 2017 from […]


Empagliflozin Effective in HFpEF

A double-blind, randomized trial revealed that empagliflozin reduced the combined risk of cardiovascular death or hospitalization for heart failure (HF) in patients with HF and a preserved ejection fraction (HFpEF), regardless of the presence or absence of diabetes. The trial included 5988 patients (average 72 years, about 45% women, and […]


Gut Microbiome Might Be the Link of Healthy Foods and Lower BP

A community-based cohort study in Germany suggested that the composition of the gut microbiome might explain the cross-sectional association of habitual flavonoid and flavonoid-rich food intake with blood pressure (BP). The study included 904 participants, and 16S ribosomal RNA was sequenced for the gut microbiome composition. Higher total flavonoid intakes […]


Plant Foods Linked to Lower CVD Risk

Two separate studies in the US suggested that plant-based foods were associated with lower risk of cardiovascular disease (CVD) in young adults andpostmenopausal women. One study included 4,946 adults, 18 to 30-years-old at the time of enrollment from 1985 to 1986; 2,509 Black and 2,437 white adults, 54.9% women overall. […]


ARBs May Be Safer Than ACE Inhibitors

A retrospective, new-user comparative cohort study revealed that angiotensin receptor blockers (ARBs) do not differ statistically significantly in effectiveness at the class level compared with ACE (angiotensin-converting enzyme) inhibitors as first-line treatment for high blood pressure but present a better safety profile. The study included all patients with high blood […]